Search results
MDMA drug for PTSD panned by FDA advisers citing trial flaws - The Boston Globe
The Boston Globe· 2 days agoAdvisers to the Food and Drug Administration voted 9 to 2 that developer Lykos Therapeutics Inc.’s...
Experimental therapy shows promise in pancreatic cancer clinical trial
Medical Xpress· 6 days agoThe findings are being presented at the American Society of Clinical Oncology 2024 annual meeting in...
Trying to solve the ‘cruel mystery,’ lupus
Post-Bulletin· 7 days agoWhile pregnant with her second child, Shamiere Schwahn noticed something was off. The symptoms she experienced, Schwahn said, were assumed to be because...
Woman diagnosed with Stage 4 cancer at 22 reveals the silent symptom to look out for
UNILAD· 7 days agoA woman diagnosed with stage 4 cancer at the age of 22 has revealed an unusual symptom to look out...
"It’s What I Call The Allergic Salute”: Doctors Are Sharing Subtle Signs That Someone Might Have...
BuzzFeed via Yahoo News· 5 days agoAnd some studies have found that allergy medication may cause ear-ringing as a side effect. If you...
A male contraceptive is only as reliable as the man taking it
Daily Telegraph· 21 hours ago“You don’t want to stop sexual function, which is why we replace the testosterone,” Blithe says....
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters via Yahoo News· 5 days agoIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who...
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters· 5 days ago, opens new tab multiple myeloma drug Blenrep nearly halved the risk of disease progression or death...
The US allows Ukraine to use its weapons to strike inside Russia, but it is unlikely to be a...
CNN via Yahoo News· 7 days agoThe story of the past 27 months since Russia invaded Ukraine has been one of crumbling taboos. After...
GSK blood cancer drug nearly halves risk of death in late-stage trial | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 5 days agoGSK’s multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared...